Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
Learn more: Cell Therapy Could Improve Brain Function for Alzheimer’s disease
The Latest on: Alzheimer’s Disease
[google_news title=”” keyword=”Alzheimers Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s Disease
- What is the first thing a person with Alzheimer's forgets?on May 13, 2024 at 5:49 am
According to experts these are the first signs of Alzheimer's disease. The National Institute on Aging in the United States refers to Alzheimer's disease as a brain disorder that slowly impedes a ...
- Alzheimer’s vaccine licensing deal boosts AC Immuneon May 13, 2024 at 5:47 am
AC Immune shares jumped more than 50% premarket on Monday after the company announced a licensing deal with Takeda Pharmaceutical Co. for its ...
- Lisa Jarvis: Would you get tested for an Alzheimer’s gene?on May 13, 2024 at 4:45 am
In a new paper in "Nature Medicine," an international team of neurologists makes the compelling case that people with two copies of a gene called APOE4 aren’t just at risk ...
- Stressful life events can increase your risk of Alzheimer’son May 13, 2024 at 4:21 am
Being arrested, getting a divorce, losing your job – all of these things are associated with an increased risk of developing Alzheimer’s.
- AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Diseaseon May 13, 2024 at 4:07 am
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s DiseaseTakeda to ...
- Amplity Health Study Sheds Light on Alzheimer's Disease's Toll on Quality of Lifeon May 13, 2024 at 4:00 am
LANGHORNE, PA — Amplity Health, a leading Contract Sales and Medical Outsourcing Partner, unveiled insights into the profound impact of Alzheimer’s disease (AD) on patients’ quality of life. The ...
- More sleepless nights probable as Alzheimer's patient's disease progresseson May 13, 2024 at 3:01 am
Yes, the sleep/wake cycle of the affected individual becomes more disturbed as Alzheimer’s disease progresses. Some people may sleep for prolonged periods during the day and night, and others may wake ...
- Nutrition and Alzheimer's disease may be linked, study findson May 12, 2024 at 3:45 am
Malnutrition may increase a person’s chances of contracting Alzheimer’s disease, which in turn exacerbates malnutrition. That’s according to a March 2024 study out of China published in Frontiers ...
- Alzheimer's Newson May 10, 2024 at 5:00 pm
Their technique will help scientists differentiate synthetic peptides from toxic types found in Alzheimer's ... Nanomaterial That Mimics Proteins Could Be Basis for New Neurodegenerative Disease ...
via Bing News